Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Charles River Laboratories International Inc C.CRL


Primary Symbol: CRL

Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.


NYSE:CRL - Post by User

Post by chesterchew1234on Nov 13, 2019 3:20pm
145 Views
Post# 30346848

carl update

carl updateI raised the issue of spending and having to go to the pp well again with Greg Johnston this morning - see below.   The company is wanting to keep shares tightly held and minimize no.s.   They probably could have got more than $800,000 from their last recent pp but in keeping with goals felt this was all the money they needed.   As I suspected, what shows up as cash expenditure in marketing expense is mostly share issuance to cover debt etc. They have chosen to promote  themselves globally with added cost as opposed to staying in their own backyard.   I am sure this was done in consultation with PRC etc., who having evaluated their product and felt it was a good gamble to grow the business quicker.  As I have mentioned, management is very approachable and better to get answers from the horses mouth as opposed to using this forum for information.  don't get mired in small details here.  From what I have seen of other junior companie's operations, these guys are the real deal.  continue to be patient. 


Hi Chesterchew – stock has been awarded for IR and other related business development activities above and beyond the day to day operational activities of the company.  As the price has tripled over the last 6 months and laid the framework for many of our revenue expansion plans, I think this is money well spent (i.e. market cap of company is now 3X what it was).  Operationally, we are extremely close to break even. I stand by my original statement that this will be done by end of year.  Financing is being done by a growing list of very strong supporters – we did an $800,000 PP for $0.20!!!!!!  Cash is not the problem.  We are a tech company that deals with governments and very large clients.  Things happen slowly but when then do – revenue increases significantly!  Also – we have our core group in place.  There is no need to expand the company with the exception of support and Sales and Marketing – meaning – profitably expands rapidly after breakeven.
 
Hope this helps.

Bullboard Posts